Closest-ever images of the Sun captured by Nasa probe
03:27
NASA has released the closest-ever images of the Sun, captured just 3.8 million miles from its surface.
Since its launch in 2018, the Parker Solar Probe has gradually circled closer to the sun, flying past Venus to use the planet's gravity to move it into a tighter orbit.
Newly released footage shows historic close-up images captured during the spacecraft 's closest approach to the Sun on December 24, 2024.
'This new data will help us vastly improve our space weather predictions to ensure the safety of our astronauts and the protection of our technology here on Earth and throughout the solar system,' said Nicky Fox, associate administrator for NASA's Science Mission Directorate.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
NIH executive fired amid allegations of steering $3.3 million contract to company that named his wife as a potential staffer
A senior leader at the National Institutes of Health has been fired as officials investigate a multi-million-dollar contract with a company that named his wife among potential staff. NIH Chief Operating Officer Eric Schnabel was escorted out of the agency's headquarters in Bethesda, Maryland, on Monday, The Washington Post reports, citing three anonymous officials with knowledge of the incident. He was hired in April, and his departure was so abrupt that some of his employees still showed up to meetings scheduled with him for Tuesday, only to discover he had been fired, according to the outlet. Eric Schnabel was removed from his post as the agency investigates a $3.3 million contract to Argo Chasing, a Louisiana company that named his wife, Trish Duffy Schnabel, on a list of prospective staff, the Post reports. The NIH approved the contract earlier this month. The award is designed to support research on several topics, including counterintelligence, strategic research security and autism, the Post reports. Health and Human Services Secretary Robert F. Kennedy Jr. vowed to direct agency resources toward researching autism earlier this year. Trish Schnabel is a licensed professional counselor. She would have been among those supported by the contract, but she would not have received the full $3.3 million, the anonymous officials told the Post. She was being onboarded as a senior analyst in the company's Division of Program Coordination, Planning, and Strategic Initiatives, the Post reports, citing an internal company document. Trish Schnabel also appears to have competed on the U.S. game show Wheel of Fortune in January 2020, winning tens of thousands of dollars, including $50,000 from the bonus round. Eric Schnabel joined the NIH in April, as Elon Musk's Department of Government Efficiency was gutting federal agencies. He came to the NIH after more than 20 years in the U.S. Army. An NIH spokesperson told The Independent the agency does not comment on personnel matters. Argo Chasing also declined to comment. The NIH saw widespread cuts to their agency this spring, forcing them to abruptly cancel more than 2,000 research grants valued at more than $12 billion. These cuts have impacted patients in clinical trials, with the agency forced to cut off medication regimens to some participants or leave them with unmonitored device implants, the Associated Press reports. Nearly 100 NIH staff sent a letter to the agency's leader, Jay Bhattacharya, last month expressing concerns with the cuts. "The life-and-death nature of our work demands that changes be thoughtful and vetted. We are compelled to speak up when our leadership prioritizes political momentum over human safety and faithful stewardship of public resources," the letter reads. "Many have raised these concerns to NIH leadership, yet we remain pressured to implement harmful measures,' it continues. 'Today, we come directly to you."
The Independent
an hour ago
- The Independent
Scientists witness birth of solar system in unique spectacle
Scientists have for the first time observed a solar system in the earliest stages of its formation. Using a powerful telescope, researchers witnessed the initial material clumping together to form planets. This breakthrough offers new insights into how solar systems, including our own, develop. The nascent system is forming around HOPS-315, a young star approximately 1300 light-years from Earth. The observations captured the very beginning of planet formation within the star's protoplanetary disc.
The Independent
an hour ago
- The Independent
Magic Mushrooms could lengthen your lifespan
A new study from Emory University suggests that psilocybin, the active compound in magic mushrooms, may extend your lifespan. Scientists at the university's department of medicine in Atlanta discovered that psilocybin increased cellular longevity and enhanced survival rates in aged mice. The study, published last week in the journal Nature, defined Psilocybin as the "naturally occurring psychedelic compound produced by hallucinogenic mushrooms.' Researchers noted growing interest in psilocybin for treating psychiatric and neurodegenerative conditions, but this study offers the first experimental evidence that psilocin, its active form, boosts longevity in aged mice. The study suggests psilocybin may be a powerful anti-aging agent, with data showing it reduces oxidative stress, prevents DNA damage and helps preserve telomere length, which all help slow the aging process. The older white-haired mice even appeared younger after treatment, regrowing black hair. "Psilocybin appears to slow the 'wear and tear' that accompanies aging," co-author of the study, Louise Hecker of Emory University, told Fox News Digital. "Mice and cells are healthier and live significantly longer." While the study suggests this could also work for humans, much more testing is needed. Hecker told the outlet that researchers need to answer questions such as, "What are the optimal dosing protocols for humans? What is the optimal age for treatment initiation for optimal benefits?" "Is there an age, beyond which point, when treatment does not provide efficacy?' she continued. 'Are there potential harms or adverse effects associated with long-term treatment? What are the mechanisms of its action? All these questions need to be rigorously tested." Gabe Charambides, founder of the U.S.' first legal psilocybin retreat in Oregon, called the findings 'compelling' but stressed that human use requires stricter screening, preparation and safety than in mice. He added that those who may benefit most from psilocybin therapy are people feeling 'stuck' after major life events, such as childhood trauma, divorce, job loss or bereavement, or those seeking to improve their mental health. Charambides said his retreat guests have reported relief from physical issues such as chronic pain and migraines, though no biological testing is conducted. Ryan Moss of Filament Health, a Canadian clinical-stage natural psychedelic drug development company, previously stressed to Fox News Digital that the use of psychedelics should be administered in a safe, controlled setting. "Psychedelic experiences can sometimes feature anxiety, hallucinations, and paranoia," Moss said. "Some patients using traditional psychedelics have reported experiencing adverse cardiovascular events during clinical trials." He recommends that clinical trial participants be well-prepared and closely monitored by trained professionals.
